HD-OPM Archive
Topics › Weight, visceral & liver fat

Metabolically healthy obesity still carried 39% higher CVD risk over 20 years in ATTICA

Louis Nervegna · May 05, 2026 · ♥ 3 reactions · 3 comments · original Facebook post
Weight, visceral & liver fatCardiovascular disease: the big picture
AI summary & key facts

A shared SuppVersity summary of the 20-year Greek ATTICA cohort (3,042 adults): metabolically healthy obesity had HR 1.39 for CVD versus metabolically healthy normal weight, and unhealthy obesity HR 1.85.

People who are obese, but otherwise metabolically healthy, are still at considerably higher risk for CVD.

#obesityHD #weightlossHD #cvdHD

Research cited

Shared from SuppVersity · original post

"Metabolically Healthy Obesity" Still Raises Heart Risk by 39% – So Is "Health at Every Size" Honest About the Heart?"

Numbers first: Over 20 years, so‑called metabolically healthy obesity (MHO) carried a 🫀 39% higher cardiovascular risk 💔 vs metabolically healthy, normal‑weight peers (HR 1.39, 95% CI 1.06–3.42).

Metabolically unhealthy obesity fared worse with an 85% higher risk (HR 1.85, 95% CI 1.02–3.58). Crude CVD incidence: 21.3% in MHWO vs 37.1% in MHO and 61.1% in MUO.

The data stems from a 20‑year prospective cohort, involving 3042 adults in Greece (ATTICA Study) - 3 follow‑ups, Cox models adjusted for age, sex, smoking, Mediterranean diet, LDL‑C, CRP, SBP, HOMA‑IR.

The authors conclude that "individuals with obesity exhibit higher CVD risk ... regardless of metabolic health status." That does not mean shaming bodies; it means being honest about biology. Weight‑neutral support, stigma‑free care, and acknowledging that extra adiposity is not cardiologically neutral can coexist. "Healthy at every size" is a nice slogan; the left ventricle, unfortunately, did not sign off on it.

SuppVersity | Filippatos, T.D., Katrapas, P., Tsiampalis, T. et al. Metabolically healthy obesity is independently associated with 20-year incidence of cardiovascular disease: findings from the ATTICA cohort study (2002–2022). Int J Obes (2026). DOI: 10.1038/s41366-026-02056-9

← newer: Multiple studies show EVOO improves FMD, contradicting Esselolder: Under 1% of oral berberine reaches the blood, so it likely a →